Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vivani Medical Inc | Gregg G. Williams | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.62 per share. | 27 Oct 2025 | 3,703,703 | 21,350,815 | - | 1.6 | 5,999,999 | Common Stock |
| Blend Labs Inc (Class A) | Jason Ream | Head of Finance and Admin. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 2,200,000 | 2,200,000 | - | - | Restricted Stock Units | |
| Neumora Therapeutics Inc | Kristina M. Burow | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.61 per share. | 27 Oct 2025 | 1,915,700 | 6,046,907 | - | 2.6 | 4,999,977 | Common Stock |
| Kinder Morgan (Class P) | Richard D. Kinder | Director, Executive Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 25.96 per share. | 27 Oct 2025 | 1,000,000 | 246,212,353 (10%) | 0% | 26.0 | 25,964,900 | Class P Common Stock |
| MapLight Therapeutics Inc | Christopher A. Kroeger | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 916,164 | 916,164 | - | - | Employee Stock Option (right to buy) | |
| ACM Research Inc (Class A) | David H. Wang | Director, See Remarks, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 545,400 | 545,400 | - | - | Stock Option | |
| Janover Inc | Parker White | COO & Chief Investment Officer, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 27 Oct 2025 | 395,295 | 2,488,992 | - | 0 | Common Stock | |
| Las Vegas Sands | Robert Glen Goldstein | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 300,000 | 1,700,000 | - | - | Option (Right to Buy) | |
| Las Vegas Sands | Robert Glen Goldstein | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.28 per share. | 27 Oct 2025 | 300,000 | 300,000 (0%) | 0% | 34.3 | 10,284,000 | Common Stock |
| Janover Inc | Parker White | COO & Chief Investment Officer, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 27 Oct 2025 | 288,428 | 288,428 | - | - | Warrant (Right to buy) | |
| Janover Inc | Parker White | COO & Chief Investment Officer, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 27 Oct 2025 | 288,428 | 0 | - | - | Warrant (Right to buy) | |
| Janover Inc | Joseph Onorati | Director, CEO & Chairman, Ten Percent Owner | Other type of transaction at price $ 4.96 per share. | 27 Oct 2025 | 271,043 | 271,043 | - | 5.0 | 1,344,373 | Common Stock |
| Janover Inc | Parker White | COO & Chief Investment Officer, Ten Percent Owner | Other type of transaction at price $ 4.96 per share. | 27 Oct 2025 | 271,043 | 333,841 | - | 5.0 | 1,344,373 | Common Stock |
| Las Vegas Sands | Robert Glen Goldstein | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 59.40 per share. | 27 Oct 2025 | 264,588 | 0 (0%) | 0% | 59.4 | 15,716,527 | Common Stock |
| Lafayette Acquisition Corp | Christophe Charlier | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 27 Oct 2025 | 244,286 | 2,805,952 | - | - | Ordinary Shares | |
| Janover Inc | Parker White | COO & Chief Investment Officer, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 27 Oct 2025 | 242,071 | 242,071 | - | 0 | Common Stock | |
| MapLight Therapeutics Inc | Christopher A. Kroeger | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 225,693 | 225,693 | - | 0 | Voting Common Stock | |
| Janover Inc | Joseph Onorati | Director, CEO & Chairman, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 27 Oct 2025 | 221,613 | 221,613 | - | - | Warrant (Right to buy) | |
| PMV Pharmaceuticals Inc | David H. Mack | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 220,643 | 0 | - | - | Employee Stock Option (right to buy) | |
| PMV Pharmaceuticals Inc | David H. Mack | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.37 per share. | 27 Oct 2025 | 220,643 | 451,109 | - | 1.4 | 302,281 | Common Stock |
| Janover Inc | Parker White | COO & Chief Investment Officer, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 27 Oct 2025 | 220,397 | 220,397 | - | - | Warrant (Right to buy) | |
| Calisa Acquisition Corp | Na Gai | Director, Chairwoman of the Board, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Oct 2025 | 201,000 | 1,468,975 | - | 0 | Ordinary Shares | |
| MapLight Therapeutics Inc | Erin Pennock Foff | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 196,035 | 196,035 | - | - | Employee Stock Option (right to buy) | |
| MapLight Therapeutics Inc | Vishwas Setia | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 176,031 | 176,031 | - | - | Employee Stock Option (right to buy) | |
| Lyell Immunopharma Inc | Lynn Seely | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 175,000 | 175,000 | - | - | Option (right to buy) | |
| Airbnb | Joseph Gebbia | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 128.46 per share. | 27 Oct 2025 | 153,474 | 523,148 | - | 128.5 | 19,715,024 | Class A Common Stock |
| MapLight Therapeutics Inc | Anatol Kreitzer | Chief Discovery Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 146,052 | 146,052 | - | - | Employee Stock Option (right to buy) | |
| MapLight Therapeutics Inc | Robert C. Malenka | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 139,610 | 139,610 | - | - | Employee Stock Option (right to buy) | |
| MapLight Therapeutics Inc | James Lillie | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 132,023 | 132,023 | - | - | Employee Stock Option (right to buy) | |
| MapLight Therapeutics Inc | Jonathan Gillis | CAAO and PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 124,022 | 124,022 | - | - | Employee Stock Option (right to buy) | |
| Cyclacel Pharma Inc | Kim Choy Yap | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.12 per share. | 27 Oct 2025 | 120,250 | 264,620 (1%) | 0% | 2.1 | 254,690 | Common Stock |
| MapLight Therapeutics Inc | Kristopher L. Hanson | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 110,046 | 110,046 | - | - | Employee Stock Option (right to buy) | |
| Dawson Geophysical Co | Ray L. Mays | EVP & Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 100,000 | 108,500 (0%) | 0% | 0 | Dawson Geophysical Company-Common Stock $0.01 par value | |
| Nuvation Bio Inc (Class A) | Gary Hattersley | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 100,000 | 298,935 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc (Class A) | Gary Hattersley | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 5.02 per share. | 27 Oct 2025 | 100,000 | 0 | - | 5.0 | 502,460 | Class A Common Stock |
| Nuvation Bio Inc (Class A) | Gary Hattersley | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.74 per share. | 27 Oct 2025 | 100,000 | 100,000 | - | 1.7 | 174,000 | Class A Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 1.55 per share. | 27 Oct 2025 | 86,154 | 4,132,715 | - | 1.6 | 133,539 | Common Stock |
| Micron Tech | Scott J. Deboer | EVP, CTO and Products Officer | Sale of securities on an exchange or to another person at price $ 222.81 per share. | 27 Oct 2025 | 82,000 | 154,145 (0%) | 0% | 222.8 | 18,270,420 | Common Stock |
| Waterstone Fin Inc | Michael L. Hansen | Director | 27 Oct 2025 | 79,872 | 0 (0%) | 0% | 15.2 | 1,210,860 | Common Stock | |
| Lyell Immunopharma Inc | Stephen Hill | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 75,000 | 75,000 | - | - | Option (right to buy) | |
| PBF Energy Inc (Class A) | Matthew C. Lucey | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 70,372 | 456,319 (0%) | 0% | 0 | Class A Common Stock | |
| Viking Therapeutics Inc | Brian Lian | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 70,084 | 2,458,098 (3%) | 0% | 0 | Common Stock, par value $0.00001 per share | |
| Lyell Immunopharma Inc | Gary Lee | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 68,000 | 68,000 | - | - | Option (right to buy) | |
| Citizens Financial Group | Aunoy Banerjee | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 67,424 | 67,424 (0%) | 0% | 0 | Common Stock | |
| MapLight Therapeutics Inc | Christopher A. Kroeger | Director, Chief Executive Officer | 27 Oct 2025 | 65,477 | 0 | - | - | Series C Preferred Stock | ||
| MapLight Therapeutics Inc | Robert C. Malenka | Director | 27 Oct 2025 | 65,477 | 0 | - | - | Series C Preferred Stock | ||
| Janover Inc | Parker White | COO & Chief Investment Officer, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 27 Oct 2025 | 60,488 | 60,488 | - | - | Warrant (Right to buy) | |
| Viking Therapeutics Inc | Charles A. Rowland | Director | Sale of securities on an exchange or to another person at price $ 35.57 per share. | 27 Oct 2025 | 60,000 | 30,000 (0%) | 0% | 35.6 | 2,134,278 | Common Stock, par value $0.00001 per share |
| Airsculpt Tech Inc | Yogesh Jashnani | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 56,097 | 164,289 | - | - | Performance Stock Units | |
| Airsculpt Tech Inc | Yogesh Jashnani | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 56,097 | 520,976 | - | - | Common Stock, $0.001 Par Value | |
| Airbnb | Joseph Gebbia | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 129.14 per share. | 27 Oct 2025 | 55,133 | 468,015 | - | 129.1 | 7,120,118 | Class A Common Stock |
| Capital One | Richard D. Fairbank | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 63.73 per share. | 27 Oct 2025 | 53,486 | 4,154,714 (0%) | 0% | 63.7 | 3,408,663 | Common Stock |
| Capital One | Richard D. Fairbank | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 53,486 | 53,487 | - | - | Stock Options | |
| Cartesian Therapeutics Inc | June Ann Seymour | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 50,000 | 50,000 | - | - | Employee Stock Option (right to buy) | |
| Acadia Healthcare Co Inc | Todd S. Young | Chief Financial Officer | 27 Oct 2025 | 48,445 | 48,445 (0%) | 0% | 0 | Common Stock | ||
| MapLight Therapeutics Inc | Erin Pennock Foff | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 48,275 | 48,275 | - | 0 | Voting Common Stock | |
| Janover Inc | Fei Han | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 27 Oct 2025 | 46,852 | 46,852 | - | - | Warrant (Right to buy) | |
| Janover Inc | Fei Han | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 27 Oct 2025 | 46,852 | 0 | - | - | Warrant (Right to buy) | |
| Janover Inc | Fei Han | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 27 Oct 2025 | 46,852 | 46,852 | - | - | Warrant (Right to buy) | |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 1.72 per share. | 27 Oct 2025 | 46,664 | 4,263,196 | - | 1.7 | 80,262 | Common Stock |
| UiPath Inc (Class A) | Daniel Dines | Director, CEO and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 16.29 per share. | 27 Oct 2025 | 45,000 | 29,513,585 | - | 16.3 | 732,933 | Class A Commmon Stock |
| UiPath Inc (Class A) | Daniel Dines | Director, CEO and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 17.16 per share. | 27 Oct 2025 | 45,000 | 29,558,585 | - | 17.2 | 772,344 | Class A Commmon Stock |
| UiPath Inc (Class A) | Daniel Dines | Director, CEO and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 16.73 per share. | 27 Oct 2025 | 45,000 | 29,603,585 | - | 16.7 | 752,670 | Class A Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 1.64 per share. | 27 Oct 2025 | 44,327 | 4,218,869 | - | 1.6 | 72,696 | Common Stock |
| PubMatic Inc Ordinary Shares | Rajeev K. Goel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 27 Oct 2025 | 44,000 | 210,984 | - | - | Class B Common Stock | ||
| PubMatic Inc Ordinary Shares | Rajeev K. Goel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 44,000 | 254,984 | - | - | Class B Common Stock | |
| PubMatic Inc Ordinary Shares | Rajeev K. Goel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 44,000 | 70,753 | - | - | Stock Option (Right to buy Class B Common Stock) | |
| PubMatic Inc Ordinary Shares | Rajeev K. Goel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.72 per share. | 27 Oct 2025 | 44,000 | 0 | - | 8.7 | 383,706 | Class A Common Stock |
| PubMatic Inc Ordinary Shares | Rajeev K. Goel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 27 Oct 2025 | 44,000 | 44,000 | - | - | Class A Common Stock | ||
| MapLight Therapeutics Inc | Vishwas Setia | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 43,367 | 43,367 | - | 0 | Voting Common Stock | |
| Viking Therapeutics Inc | Brian Lian | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 35.01 per share. | 27 Oct 2025 | 38,989 | 2,419,109 (3%) | 0% | 35.0 | 1,364,923 | Common Stock, par value $0.00001 per share |
| Neogen Corp | John E. Adent | Former CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.19 per share. | 27 Oct 2025 | 38,759 | 371,608 (0%) | 0% | 6.2 | 239,918 | Common Stock |
| Neogen Corp | John E. Adent | Former CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 38,759 | 38,759 | - | - | Restricted Stock Units | |
| MapLight Therapeutics Inc | Anatol Kreitzer | Chief Discovery Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 35,953 | 35,953 | - | 0 | Voting Common Stock | |
| Las Vegas Sands | Robert Glen Goldstein | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 58.75 per share. | 27 Oct 2025 | 35,412 | 264,588 (0%) | 0% | 58.8 | 2,080,455 | Common Stock |
| VistaGen Therapeutics Inc | Paul R. Edick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 35,200 | 35,200 | - | - | Stock Option (Right to Buy) | |
| MapLight Therapeutics Inc | Robert C. Malenka | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 34,390 | 399,671 | - | 0 | Voting Common Stock | |
| MapLight Therapeutics Inc | James Lillie | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 32,539 | 32,539 | - | 0 | Voting Common Stock | |
| Nuvalent Inc (Class A) | Matthew Shair | Director | Sale of securities on an exchange or to another person at price $ 100.27 per share. | 27 Oct 2025 | 32,455 | 1,383,044 | - | 100.3 | 3,254,263 | Class A Common Stock |
| Gabelli Multimedia Trust Inc | Mario J. Gabelli | Director, Control Person of Adviser | Purchase of securities on an exchange or from another person at price $ 4.04 per share. | 27 Oct 2025 | 31,000 | 31,000 (0%) | 0% | 4.0 | 125,138 | Common Stock, Par Value $0.001 |
| MapLight Therapeutics Inc | Jonathan Gillis | CAAO and PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 30,565 | 30,565 | - | 0 | Voting Common Stock | |
| PBF Energy Inc (Class A) | T. Paul Davis | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 30,353 | 192,391 (0%) | 0% | 0 | Class A Common Stock | |
| PBF Energy Inc (Class A) | James E. Fedena | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 30,353 | 164,203 (0%) | 0% | 0 | Class A Common Stock | |
| PBF Energy Inc (Class A) | Thomas L. O'Connor | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 30,353 | 205,340 (0%) | 0% | 0 | Class A Common Stock | |
| PBF Energy Inc (Class A) | Trecia M. Canty | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 30,353 | 200,744 (0%) | 0% | 0 | Class A Common Stock | |
| PBF Energy Inc (Class A) | Wendy Ho Tai | Senior Vice President, HR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 30,353 | 136,973 (0%) | 0% | 0 | Class A Common Stock | |
| PBF Energy Inc (Class A) | Joseph Daniel Marino | SVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 30,353 | 50,000 (0%) | 0% | 0 | Class A Common Stock | |
| Equifax | Mark W. Begor | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 191.44 per share. | 27 Oct 2025 | 27,959 | 170,940 (0%) | 0% | 191.4 | 5,352,471 | Common Stock |
| Equifax | Mark W. Begor | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 27,959 | 0 | - | - | Stock Option/Right to Buy | |
| Credo Tech Grp Holding Ltd | Chi Fung Cheng | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 155.44 per share. | 27 Oct 2025 | 27,850 | 6,691,454 | - | 155.4 | 4,329,068 | Ordinary Shares |
| HP Inc. | Anneliese Olson | Pres Imaging Prtng & Solutions | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 27,751 | 27,567 | - | - | Restricted Stock Units | |
| HP Inc. | Anneliese Olson | Pres Imaging Prtng & Solutions | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 27,751 | 27,920 (0%) | 0% | 0 | Common Stock | |
| Janover Inc | Joseph Onorati | Director, CEO & Chairman, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 27 Oct 2025 | 27,104 | 27,104 | - | - | Warrant (Right to buy) | |
| Janover Inc | Parker White | COO & Chief Investment Officer, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 27 Oct 2025 | 27,104 | 33,384 | - | - | Warrant (Right to buy) | |
| MapLight Therapeutics Inc | Kristopher L. Hanson | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 27,098 | 27,098 | - | 0 | Voting Common Stock | |
| Travel+Leisure Co | Geoffrey Richards | See Remarks | Sale of securities on an exchange or to another person at price $ 66.06 per share. | 27 Oct 2025 | 26,838 | 112,777 (0%) | 0% | 66.1 | 1,772,803 | Common Stock |
| MapLight Therapeutics Inc | Maria C. Walker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 25,604 | 25,604 | - | - | Employee Stock Option (right to buy) | |
| MapLight Therapeutics Inc | Timothy John Garnett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 25,604 | 25,604 | - | - | Employee Stock Option (right to buy) | |
| Upland Software Inc | Stephen E. Courter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 25,000 | 124,232 (0%) | 0% | 0 | Common Stock | |
| Upland Software Inc | David D. May | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 25,000 | 191,437 (0%) | 0% | 0 | Common Stock | |
| Upland Software Inc | Timothy W. Mattox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 25,000 | 419,008 (1%) | 0% | 0 | Common Stock | |
| Upland Software Inc | Teresa Miles Walsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 25,000 | 144,490 (0%) | 0% | 0 | Common Stock | |
| Chubb | John J. Lupica | Vice Chrm, Chubb Group* | Exercise or conversion of derivative security received from the company (such as an option) at price $ 118.39 per share. | 27 Oct 2025 | 23,698 | 114,298 (0%) | 0% | 118.4 | 2,805,606 | Common Shares |
| Chubb | John J. Lupica | Vice Chrm, Chubb Group* | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 23,698 | 0 | - | - | Options to Acquire Common Shares | |
| Chubb | John J. Lupica | Vice Chrm, Chubb Group* | Sale of securities on an exchange or to another person at price $ 281.00 per share. | 27 Oct 2025 | 23,698 | 90,600 (0%) | 0% | 281 | 6,659,138 | Common Shares |
| Vistra | James A. Burke | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 22,011 | 9,641 | - | - | 2018 Employee Stock Option (right to buy) | |
| Vistra | James A. Burke | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.68 per share. | 27 Oct 2025 | 22,011 | 319,440 (0%) | 0% | 19.7 | 433,176 | Common Stock |
| Viking Therapeutics Inc | Charles A. Rowland | Director | Grant, award, or other acquisition of securities at price $ 4.88 per share. | 27 Oct 2025 | 22,000 | 90,000 (0%) | 0% | 4.9 | 107,360 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Charles A. Rowland | Director | Grant, award, or other acquisition of securities at price $ 5.80 per share. | 27 Oct 2025 | 22,000 | 68,000 (0%) | 0% | 5.8 | 127,600 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Charles A. Rowland | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 22,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Viking Therapeutics Inc | Charles A. Rowland | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 22,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Capital One | Richard D. Fairbank | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 226.43 per share. | 27 Oct 2025 | 21,429 | 4,103,350 (0%) | 0% | 226.4 | 4,852,168 | Common Stock |
| Lindsay Corp | Randy A. Wood | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 21,356 | 21,356 | - | - | Option to Purchase | |
| Healthcare Services Grp Inc | Jason J. Bundick | EVP/Gen. Counsel/Corp. Secty. | Sale or transfer of securities back to the company at price $ 19.04 per share. | 27 Oct 2025 | 20,996 | 20,509 (0%) | 0% | 19.0 | 399,764 | Common Stock |
| Vistra | James A. Burke | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 203.64 per share. | 27 Oct 2025 | 20,473 | 298,967 (0%) | 0% | 203.6 | 4,169,122 | Common Stock |
| Fastly Inc (Class A) | Artur Bergman | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 8.34 per share. | 27 Oct 2025 | 20,000 | 3,361,276 (4%) | 0% | 8.3 | 166,800 | Class A Common Stock |
| Ladder Cap Corp (Class A) | Jeffrey B. Steiner | Director | Sale of securities on an exchange or to another person at price $ 10.89 per share. | 27 Oct 2025 | 19,481 | 27,311 (0%) | 0% | 10.9 | 212,148 | Class A Common Stock |
| Capital One | Richard D. Fairbank | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 226.43 per share. | 27 Oct 2025 | 19,466 | 4,053,251 (0%) | 0% | 226.4 | 4,407,686 | Common Stock |
| Medpace Holdings Inc | Jesse J Geiger | President | 27 Oct 2025 | 19,460 | 3,568 | - | - | Employee Stock Option (Right to Buy) | ||
| Medpace Holdings Inc | Jesse J Geiger | President | 27 Oct 2025 | 19,460 | 55,963 (0%) | 0% | 166.7 | 3,244,566 | Common Stock | |
| Medpace Holdings Inc | Jesse J Geiger | President | 27 Oct 2025 | 19,460 | 36,503 (0%) | 0% | 605.1 | 11,775,635 | Common Stock | |
| Medpace Holdings Inc | Stephen P Ewald | General Counsel & Corp. Secy. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 18,230 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Medpace Holdings Inc | Stephen P Ewald | General Counsel & Corp. Secy. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 166.73 per share. | 27 Oct 2025 | 18,230 | 28,573 (0%) | 0% | 166.7 | 3,039,488 | Common Stock |
| HP Inc. | Anneliese Olson | Pres Imaging Prtng & Solutions | Sale of securities on an exchange or to another person at price $ 27.88 per share. | 27 Oct 2025 | 18,154 | 169 (0%) | 0% | 27.9 | 506,134 | Common Stock |
| Capital One | Richard D. Fairbank | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 225.39 per share. | 27 Oct 2025 | 17,167 | 4,124,779 (0%) | 0% | 225.4 | 3,869,270 | Common Stock |
| Micron Tech | Sanjay Mehrotra | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 220.17 per share. | 27 Oct 2025 | 17,018 | 452,060 (0%) | 0% | 220.2 | 3,746,853 | Common Stock |
| CervoMed Inc | David Quigley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 16,200 | 16,200 | - | - | Stock Option (Right to Buy) | |
| Viking Therapeutics Inc | Charles A. Rowland | Director | Grant, award, or other acquisition of securities at price $ 4.48 per share. | 27 Oct 2025 | 16,000 | 46,000 (0%) | 0% | 4.5 | 71,680 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Charles A. Rowland | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 16,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Northwest Bancshares Inc | Erin Freund Siegfried | Chief Legal Counsel /Corp Sec | 27 Oct 2025 | 15,988 | 15,988 (0%) | 0% | 12.5 | 200,010 | Northwest Bancshares, Inc. Common Stock | |
| Capital One | Richard D. Fairbank | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 225.43 per share. | 27 Oct 2025 | 15,837 | 4,072,717 (0%) | 0% | 225.4 | 3,570,135 | Common Stock |
| Airbnb | Joseph Gebbia | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 127.53 per share. | 27 Oct 2025 | 15,704 | 676,622 | - | 127.5 | 2,002,657 | Class A Common Stock |
| Neogen Corp | David H. Naemura | Chief Financial Officer | 27 Oct 2025 | 15,504 | 85,285 (0%) | 0% | 6.2 | 95,970 | Common Stock | |
| Neogen Corp | David H. Naemura | Chief Financial Officer | 27 Oct 2025 | 15,504 | 15,504 | - | - | Restricted Stock Units | ||
| Neogen Corp | Douglas E. Jones | Former COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.19 per share. | 27 Oct 2025 | 15,504 | 104,362 (0%) | 0% | 6.2 | 95,970 | Common Stock |
| Neogen Corp | Douglas E. Jones | Former COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 15,504 | 15,504 | - | - | Restricted Stock Units | |
| Hagerty Inc (Class A) | Robert I. Kauffman | Director | Sale of securities on an exchange or to another person at price $ 11.12 per share. | 27 Oct 2025 | 15,270 | 898,097 | - | 11.1 | 169,802 | Class A Common Stock |
| Medpace Holdings Inc | Stephen P Ewald | General Counsel & Corp. Secy. | Sale of securities on an exchange or to another person at price $ 598.85 per share. | 27 Oct 2025 | 15,230 | 13,343 (0%) | 0% | 598.9 | 9,120,486 | Common Stock |
| NextNRG Inc | Avishai Vaknin | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 2.00 per share. | 27 Oct 2025 | 15,000 | 284,204 | - | 2 | 30,000 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 14,625 | 55,875 | - | - | Stock Options | |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share. | 27 Oct 2025 | 14,625 | 14,625 (0%) | 0% | 135.4 | 1,980,518 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 417.50 per share. | 27 Oct 2025 | 14,625 | 0 (0%) | 0% | 417.5 | 6,105,886 | Common Stock |
| Nuvalent Inc (Class A) | Matthew Shair | Director | Sale of securities on an exchange or to another person at price $ 100.23 per share. | 27 Oct 2025 | 14,345 | 1,415,499 | - | 100.2 | 1,437,799 | Class A Common Stock |
| Capital One | Richard D. Fairbank | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 224.53 per share. | 27 Oct 2025 | 12,768 | 4,141,946 (0%) | 0% | 224.5 | 2,866,799 | Common Stock |
| Capital One | Richard D. Fairbank | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 224.56 per share. | 27 Oct 2025 | 12,674 | 4,088,554 (0%) | 0% | 224.6 | 2,846,073 | Common Stock |
| Aldel Fin II Inc (Class A) | Robert I. Kauffman | Director, Chief Executive Officer, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 27 Oct 2025 | 12,500 | 87,500 | - | - | Class B ordinary shares | |
| Aldel Fin II Inc (Class A) | Peter Early | See Remarks | 27 Oct 2025 | 12,500 | 12,500 | - | - | Class B ordinary shares | ||
| Vicor Corp | Sean Crilly | Corp. VP-Eng., Pwr Syst. | Sale of securities on an exchange or to another person at price $ 89.61 per share. | 27 Oct 2025 | 12,000 | 15,532 (0%) | 0% | 89.6 | 1,075,336 | Common Stock |
| Airbnb | Joseph Gebbia | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 126.68 per share. | 27 Oct 2025 | 11,689 | 692,326 | - | 126.7 | 1,480,761 | Class A Common Stock |
| Hexcel Corp | Lilian Regis Brayle | President EMEA/AP & Industrial | 27 Oct 2025 | 11,683 | 11,683 | - | - | Restricted Stock Units | ||
| PBF Energy Inc (Class A) | Matthew C. Lucey | Director, CEO & President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.44 per share. | 27 Oct 2025 | 11,593 | 385,947 (0%) | 0% | 33.4 | 387,670 | Class A Common Stock |
| Mesa Laboratories Inc | Gary M. Owens | President and CEO | 27 Oct 2025 | 11,558 | 64,135 (1%) | 0% | 0 | Common Stock | ||
| Flex Ltd | Kwang Hooi Tan | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 64.82 per share. | 27 Oct 2025 | 11,312 | 252,324 (0%) | 0% | 64.8 | 733,212 | Ordinary Shares |
| Pegasystems Inc | Efstathios A. Kouninis | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.64 per share. | 27 Oct 2025 | 11,250 | 11,456 (0%) | 0% | 23.6 | 265,950 | Common stock |
| Pegasystems Inc | Efstathios A. Kouninis | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 11,250 | 0 | - | - | Stock Options | |
| Viking Therapeutics Inc | Greg S. Zante | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 11,117 | 179,777 (0%) | 0% | 0 | Common Stock, par value $0.00001 per share | |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 11,117 | 388,652 (0%) | 0% | 0 | Common Stock, par value $0.00001 per share | |
| Credo Tech Grp Holding Ltd | Chi Fung Cheng | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 156.38 per share. | 27 Oct 2025 | 10,696 | 6,680,758 | - | 156.4 | 1,672,616 | Ordinary Shares |
| StepStone Grp Inc (Class A) | Scott W. Hart | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 64.34 per share. | 27 Oct 2025 | 10,000 | 30,000 | - | 64.3 | 643,400 | Class A Common Stock |
| Winnebago Ind Inc | Michael J. Happe | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 10,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Winnebago Ind Inc | Michael J. Happe | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.67 per share. | 27 Oct 2025 | 10,000 | 354,606 (1%) | 0% | 16.7 | 166,700 | Common Stock, $.50 par value |
| Boston Scientific | Ellen M. Zane | Director | Sale of securities on an exchange or to another person at price $ 101.13 per share. | 27 Oct 2025 | 9,990 | 27,035 (0%) | 0% | 101.1 | 1,010,301 | Common Stock |
| HP Inc. | Anneliese Olson | Pres Imaging Prtng & Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.92 per share. | 27 Oct 2025 | 9,597 | 18,323 (0%) | 0% | 27.9 | 267,948 | Common Stock |
| Neogen Corp | Amy M. Rocklin | Chief Legal Officer | 27 Oct 2025 | 9,474 | 9,474 | - | - | Restricted Stock Units | ||
| Neogen Corp | Amy M. Rocklin | Chief Legal Officer | 27 Oct 2025 | 9,474 | 59,325 (0%) | 0% | 6.2 | 58,644 | Common Stock | |
| Nuvalent Inc (Class A) | Matthew Shair | Director | Sale of securities on an exchange or to another person at price $ 100.27 per share. | 27 Oct 2025 | 9,154 | 203,322 | - | 100.3 | 917,872 | Class A Common Stock |
| Pricesmart Inc | John D. Hildebrandt | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 123.15 per share. | 27 Oct 2025 | 9,107 | 125,615 (0%) | 0% | 123.1 | 1,121,527 | Common Stock, $0.0001 par value per share |
| First Horizon Corp | Anthony J. Restel | SEVP, Chief Banking Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.99 per share. | 27 Oct 2025 | 9,027 | 616,995 (0%) | 0% | 21.0 | 189,477 | Common Stock |
| RTX | Christopher T. Calio | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 82.35 per share. | 27 Oct 2025 | 8,938 | 90,446 (0%) | 0% | 82.3 | 736,044 | Common Stock |
| RTX | Christopher T. Calio | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 8,938 | 0 | - | - | Stock Appreciation Right | |
| Neogen Corp | John E. Adent | Former CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.19 per share. | 27 Oct 2025 | 8,527 | 363,081 (0%) | 0% | 6.2 | 52,782 | Common Stock |
| Centessa Pharma PLC (ADR) | Mario Alberto Accardi | President, Orexin Program | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 27 Oct 2025 | 8,000 | 194,394 | - | 25 | 200,000 | Ordinary Shares |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 417.50 per share. | 27 Oct 2025 | 7,875 | 130 (0%) | 0% | 417.5 | 3,287,785 | Common Stock |
| Interactive Brokers Grp Inc (Class A) | Lawrence E. Harris | Director | Sale of securities on an exchange or to another person at price $ 69.73 per share. | 27 Oct 2025 | 7,500 | 216,204 (0%) | 0% | 69.7 | 522,975 | Class A common stock |
| Winnebago Ind Inc | Michael J. Happe | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 41.38 per share. | 27 Oct 2025 | 7,105 | 347,501 (1%) | 0% | 41.4 | 294,005 | Common Stock, $.50 par value |
| Janover Inc | Parker White | COO & Chief Investment Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 6.90 per share. | 27 Oct 2025 | 7,041 | 249,112 | - | 6.9 | 48,583 | Common Stock |
| Equifax | Mark W. Begor | Director, CEO | Sale of securities on an exchange or to another person at price $ 232.19 per share. | 27 Oct 2025 | 6,943 | 142,934 (0%) | 0% | 232.2 | 1,612,086 | Common Stock |
| Interactive Brokers Grp Inc (Class A) | Lawrence E. Harris | Director | Sale of securities on an exchange or to another person at price $ 69.15 per share. | 27 Oct 2025 | 6,855 | 209,349 (0%) | 0% | 69.1 | 474,023 | Class A common stock |
| Pegasystems Inc | Efstathios A. Kouninis | SVP, Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.25 per share. | 27 Oct 2025 | 6,825 | 4,631 (0%) | 0% | 67.2 | 458,981 | Common stock |
| Iridium Comm Inc | Thomas J. Fitzpatrick | Director | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 27 Oct 2025 | 6,797 | 251,873 (0%) | 0% | 18 | 122,346 | Common Stock |
| Equifax | Mark W. Begor | Director, CEO | Sale of securities on an exchange or to another person at price $ 230.18 per share. | 27 Oct 2025 | 6,639 | 149,877 (0%) | 0% | 230.2 | 1,528,192 | Common Stock |
| Lindsay Corp | Randy A. Wood | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 6,555 | 42,519 (0%) | 0% | 0 | Common Stock | |
| Helios Tech Inc | Michael C. Connaway | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 6,500 | 6,500 | - | - | Restricted Stock Units | |
| Viasat Inc | John P. Stenbit | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 6,388 | 6,388 | - | - | restricted stock unit | |
| Viasat Inc | Richard A. Baldridge | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 6,388 | 6,388 | - | - | restricted stock unit | |
| Viasat Inc | Theresa M.H. Wise | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 6,388 | 6,388 | - | - | restricted stock unit | |
| Viasat Inc | Sean Pak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 6,388 | 6,388 | - | - | restricted stock unit | |
| Viasat Inc | Michael Paull | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 6,388 | 6,388 | - | - | restricted stock unit | |
| Viasat Inc | William LaPlante | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 6,388 | 6,388 | - | - | restricted stock unit | |
| MapLight Therapeutics Inc | Maria C. Walker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 6,294 | 6,294 | - | 0 | Voting Common Stock | |
| MapLight Therapeutics Inc | Timothy John Garnett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 6,294 | 6,294 | - | 0 | Voting Common Stock | |
| Equifax | Mark W. Begor | Director, CEO | Sale of securities on an exchange or to another person at price $ 229.20 per share. | 27 Oct 2025 | 6,227 | 156,516 (0%) | 0% | 229.2 | 1,427,255 | Common Stock |
| Viking Therapeutics Inc | Greg S. Zante | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 27 Oct 2025 | 6,185 | 173,592 (0%) | 0% | 35.0 | 216,481 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 27 Oct 2025 | 6,185 | 382,467 (0%) | 0% | 35.0 | 216,492 | Common Stock, par value $0.00001 per share |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 6,125 | 18,375 | - | - | Stock Options | |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 27 Oct 2025 | 6,125 | 6,125 (0%) | 0% | 146.0 | 894,434 | Common Stock |
| PBF Energy Inc (Class A) | Steven John Andriola | Controller & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 6,101 | 22,022 (0%) | 0% | 0 | Class A Common Stock | |
| Lam Research | Ava A. Harter | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 77.04 per share. | 27 Oct 2025 | 6,010 | 62,796 (0%) | 0% | 77.0 | 463,004 | Common Stock |
| Lam Research | Ava A. Harter | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 6,010 | 12,020 | - | - | Employee Stock Option (Right to Buy) | |
| Lam Research | Ava A. Harter | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 157.46 per share. | 27 Oct 2025 | 6,010 | 56,786 (0%) | 0% | 157.5 | 946,335 | Common Stock |
| Agilysys Inc | William David Wood | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 115.55 per share. | 27 Oct 2025 | 6,000 | 41,288 (0%) | 0% | 115.6 | 693,300 | Common Stock |
| Enova Intl Inc | David A. Fisher | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.96 per share. | 27 Oct 2025 | 6,000 | 354,223 (1%) | 0% | 24.0 | 143,760 | Common stock, par value $0.00001 per share |
| Enova Intl Inc | David A. Fisher | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 6,000 | 68,562 | - | - | Non-Qualified Stock Option (right to buy) with limited SAR | |
| Enova Intl Inc | David A. Fisher | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 122.61 per share. | 27 Oct 2025 | 6,000 | 348,223 (1%) | 0% | 122.6 | 735,667 | Common stock, par value $0.00001 per share |
| Trupanion Inc | Margaret Tooth | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 6,000 | 16,000 | - | - | Stock Option (right to buy) | |
| Trupanion Inc | Margaret Tooth | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.93 per share. | 27 Oct 2025 | 6,000 | 150,229 (0%) | 0% | 8.9 | 53,580 | Common Stock |
| Trupanion Inc | Margaret Tooth | Director, CEO | Sale of securities on an exchange or to another person at price $ 43.72 per share. | 27 Oct 2025 | 6,000 | 144,229 (0%) | 0% | 43.7 | 262,340 | Common Stock |
| Pathward Fin Inc | Brett L. Pharr | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 27 Oct 2025 | 5,952 | 59,122 (0%) | 0% | 0 | Common Stock | |
| Equifax | Mark W. Begor | Director, CEO | Sale of securities on an exchange or to another person at price $ 230.16 per share. | 27 Oct 2025 | 5,872 | 22,045 (0%) | 0% | 230.2 | 1,351,500 | Common Stock |
| Pricesmart Inc | Francisco Velasco | EVP - CLO, CRCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 123.15 per share. | 27 Oct 2025 | 5,787 | 76,335 (0%) | 0% | 123.1 | 712,669 | Common Stock, $0.0001 par value per share |
| Credo Tech Grp Holding Ltd | Chi Fung Cheng | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 157.46 per share. | 27 Oct 2025 | 5,652 | 6,675,106 | - | 157.5 | 889,944 | Ordinary Shares |
| Equifax | Mark W. Begor | Director, CEO | Sale of securities on an exchange or to another person at price $ 232.27 per share. | 27 Oct 2025 | 5,274 | 27,917 (0%) | 0% | 232.3 | 1,224,994 | Common Stock |
| Ategrity Specialty Insurance Co Holdings | Justin Cohen | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 19.41 per share. | 27 Oct 2025 | 5,200 | 5,200 | - | 19.4 | 100,938 | Common Stock |
| Pricesmart Inc | David N. Price | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 123.15 per share. | 27 Oct 2025 | 5,040 | 118,338 (0%) | 0% | 123.2 | 620,676 | Common Stock, $0.0001 par value per share |
| Centessa Pharma PLC (ADR) | Mario Alberto Accardi | President, Orexin Program | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.01 per share. | 27 Oct 2025 | 5,000 | 202,394 | - | 8.0 | 40,050 | Ordinary Shares |
| Centessa Pharma PLC (ADR) | Mario Alberto Accardi | President, Orexin Program | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 5,000 | 30,000 | - | - | Share Option (right to buy) | |
| NextNRG Inc | Avishai Vaknin | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 2.01 per share. | 27 Oct 2025 | 5,000 | 49,713 | - | 2.0 | 10,050 | Common Stock |
| NextNRG Inc | Avishai Vaknin | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 2.03 per share. | 27 Oct 2025 | 5,000 | 54,713 | - | 2.0 | 10,150 | Common Stock |
| NextNRG Inc | Avishai Vaknin | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 2.00 per share. | 27 Oct 2025 | 5,000 | 59,713 | - | 2 | 10,000 | Common Stock |
| Micron Tech | Sanjay Mehrotra | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 27 Oct 2025 | 5,000 | 441,578 (0%) | 0% | 0 | Common Stock | |
| Janover Inc | Daniel Kang | Chief Strategy Officer | Other type of transaction at price $ 0.00 per share. | 27 Oct 2025 | 4,983 | 0 | - | - | Warrant (Right to buy) | |
| Janover Inc | Daniel Kang | Chief Strategy Officer | Other type of transaction at price $ 0.00 per share. | 27 Oct 2025 | 4,983 | 4,983 | - | - | Warrant (Right to buy) | |
| Janover Inc | Daniel Kang | Chief Strategy Officer | Other type of transaction at price $ 0.00 per share. | 27 Oct 2025 | 4,983 | 4,983 | - | - | Warrant (Right to buy) | |
| Equifax | Jamil Farshchi | EVP, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 4,925 | 0 | - | - | Stock Option/Right to Buy | |
| Equifax | Jamil Farshchi | EVP, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 238.94 per share. | 27 Oct 2025 | 4,925 | 39,364 (0%) | 0% | 238.9 | 1,176,780 | Common Stock |
| Equifax | Jamil Farshchi | EVP, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 175.48 per share. | 27 Oct 2025 | 4,925 | 44,289 (0%) | 0% | 175.5 | 864,239 | Common Stock |
| RTX | Christopher T. Calio | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 178.32 per share. | 27 Oct 2025 | 4,813 | 81,508 (0%) | 0% | 178.3 | 858,278 | Common Stock |
| Credo Tech Grp Holding Ltd | Chi Fung Cheng | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 154.81 per share. | 27 Oct 2025 | 4,657 | 6,719,304 | - | 154.8 | 720,966 | Ordinary Shares |
| FingerMotion Inc | Yew Poh Leong | Director | Purchase of securities on an exchange or from another person at price $ 1.54 per share. | 27 Oct 2025 | 4,501 | 195,000 | - | 1.5 | 6,932 | Common Stock |
| Pegasystems Inc | Efstathios A. Kouninis | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 67.25 per share. | 27 Oct 2025 | 4,425 | 206 (0%) | 0% | 67.2 | 297,581 | Common stock |
| Cytokinetics Inc | Wendell D. Wierenga | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 4,375 | 0 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Cytokinetics Inc | Wendell D. Wierenga | Director | Sale of securities on an exchange or to another person at price $ 58.68 per share. | 27 Oct 2025 | 4,375 | 32,444 (0%) | 0% | 58.7 | 256,725 | Common Stock |
| Cytokinetics Inc | Wendell D. Wierenga | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.00 per share. | 27 Oct 2025 | 4,375 | 36,819 (0%) | 0% | 10 | 43,750 | Common Stock |
| Neogen Corp | David H. Naemura | Chief Financial Officer | 27 Oct 2025 | 4,261 | 81,024 (0%) | 0% | 6.2 | 26,376 | Common Stock | |
| Iradimed Corp | Roger Susi | Director, CEO, PRESIDENT, CHAIRMAN, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 77.56 per share. | 27 Oct 2025 | 4,242 | 2,328,258 (20%) | 0% | 77.6 | 329,010 | Common Stock |
| Janover Inc | Daniel Kang | Chief Strategy Officer | Purchase of securities on an exchange or from another person at price $ 6.90 per share. | 27 Oct 2025 | 4,200 | 7,181 | - | 6.9 | 28,980 | Common Stock |
| RTX | Christopher T. Calio | Director, Chairman, President and CEO | Sale or transfer of securities back to the company at price $ 178.40 per share. | 27 Oct 2025 | 4,125 | 86,321 (0%) | 0% | 178.4 | 735,900 | Common Stock |
| Nuvalent Inc (Class A) | Matthew Shair | Director | Sale of securities on an exchange or to another person at price $ 100.23 per share. | 27 Oct 2025 | 4,046 | 212,476 | - | 100.2 | 405,531 | Class A Common Stock |
| Equifax | Mark W. Begor | Director, CEO | Sale of securities on an exchange or to another person at price $ 233.01 per share. | 27 Oct 2025 | 4,015 | 162,743 (0%) | 0% | 233.0 | 935,549 | Common Stock |
| Atlassian Corp (Class A) | Michael Cannon-Brookes | Director, CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 164.60 per share. | 27 Oct 2025 | 4,009 | 344,925 (0%) | 0% | 164.6 | 659,899 | Class A Common Stock |
| Atlassian Corp (Class A) | Scott Farquhar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 164.60 per share. | 27 Oct 2025 | 4,008 | 348,582 (0%) | 0% | 164.6 | 659,735 | Class A Common Stock |
| MongoDB Inc (Class A) | Dwight Merriman | Director | Sale of securities on an exchange or to another person at price $ 345.00 per share. | 27 Oct 2025 | 4,000 | 1,065,316 (2%) | 0% | 345 | 1,380,000 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 4,000 | 150,000 | - | - | Stock Option | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 4,000 | 146,000 | - | - | Stock Option | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 120.26 per share. | 27 Oct 2025 | 4,000 | 4,130 (0%) | 0% | 120.3 | 481,040 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 120.26 per share. | 27 Oct 2025 | 4,000 | 4,130 (0%) | 0% | 120.3 | 481,040 | Common Stock |
| Equifax | Mark W. Begor | Director, CEO | Sale of securities on an exchange or to another person at price $ 229.12 per share. | 27 Oct 2025 | 3,995 | 33,191 (0%) | 0% | 229.1 | 915,337 | Common Stock |
| First Horizon Corp | Tammy S. LoCascio | SEVP, Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.99 per share. | 27 Oct 2025 | 3,909 | 350,376 (0%) | 0% | 21.0 | 82,050 | Common Stock |
| MapLight Therapeutics Inc | Christopher A. Kroeger | Director, Chief Executive Officer | 27 Oct 2025 | 3,895 | 229,588 | - | - | Voting Common Stock | ||
| MapLight Therapeutics Inc | Robert C. Malenka | Director | 27 Oct 2025 | 3,895 | 31,672 | - | - | Voting Common Stock | ||
| Pricesmart Inc | Wayne J. Sadin | EVP and CIO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 123.15 per share. | 27 Oct 2025 | 3,799 | 52,126 (0%) | 0% | 123.2 | 467,847 | Common Stock, $0.0001 par value |
| Equifax | Mark W. Begor | Director, CEO | Sale of securities on an exchange or to another person at price $ 231.46 per share. | 27 Oct 2025 | 3,757 | 166,758 (0%) | 0% | 231.5 | 869,590 | Common Stock |
| Natera Inc | Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 191.46 per share. | 27 Oct 2025 | 3,680 | 149,840 (0%) | 0% | 191.5 | 704,580 | Common Stock |
| Medpace Holdings Inc | Jesse J Geiger | President | 27 Oct 2025 | 3,568 | 36,503 (0%) | 0% | 585 | 2,087,280 | Common Stock | |
| Medpace Holdings Inc | Jesse J Geiger | President | 27 Oct 2025 | 3,568 | 0 | - | - | Employee Stock Option (Right to Buy) | ||
| Medpace Holdings Inc | Jesse J Geiger | President | 27 Oct 2025 | 3,568 | 40,071 (0%) | 0% | 166.7 | 594,893 | Common Stock | |
| Neogen Corp | William T. Boehm | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 3,553 | 0 | - | - | Restricted Stock Units | |
| Neogen Corp | William T. Boehm | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.07 per share. | 27 Oct 2025 | 3,553 | 47,913 (0%) | 0% | 6.1 | 21,567 | Common Stock |
| Neogen Corp | Douglas E. Jones | Former COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.19 per share. | 27 Oct 2025 | 3,481 | 100,881 (0%) | 0% | 6.2 | 21,547 | Common Stock |
| PACCAR | Brice J. Poplawski | Sr. Vice President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 3,369 | 0 | - | - | Stock Option | |
| PACCAR | Brice J. Poplawski | Sr. Vice President & CFO | Sale of securities on an exchange or to another person at price $ 101.15 per share. | 27 Oct 2025 | 3,369 | 468 (0%) | 0% | 101.2 | 340,785 | Common Stock |
| PACCAR | Brice J. Poplawski | Sr. Vice President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 62.87 per share. | 27 Oct 2025 | 3,369 | 3,837 (0%) | 0% | 62.9 | 211,798 | Common Stock |
| Equifax | Mark W. Begor | Director, CEO | Sale of securities on an exchange or to another person at price $ 231.59 per share. | 27 Oct 2025 | 3,331 | 37,186 (0%) | 0% | 231.6 | 771,439 | Common Stock |
| Iridium Comm Inc | Thomas J. Fitzpatrick | Director | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 27 Oct 2025 | 3,331 | 258,670 (0%) | 0% | 18 | 59,958 | Common Stock |
| Agios Pharma Inc | Sarah Gheuens | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 3,302 | 28,784 | - | - | Stock options (right to buy) | |
| Agios Pharma Inc | Sarah Gheuens | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 43.92 per share. | 27 Oct 2025 | 3,302 | 61,727 (0%) | 0% | 43.9 | 145,024 | Common stock |
| Agios Pharma Inc | Sarah Gheuens | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.01 per share. | 27 Oct 2025 | 3,302 | 65,029 (0%) | 0% | 25.0 | 82,583 | Common stock |
| Micron Tech | Sanjay Mehrotra | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 222.86 per share. | 27 Oct 2025 | 3,291 | 446,884 (0%) | 0% | 222.9 | 733,432 | Common Stock |
| Lindsay Corp | James Scott Marion | President - Infrastructure | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 3,203 | 3,203 | - | - | Option to Purchase | |
| Lindsay Corp | Gustavo E. Oberto | President - Irrigation | 27 Oct 2025 | 3,203 | 3,203 | - | - | Option to Purchase | ||
| PBF Energy Inc (Class A) | Karen B. Davis | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.44 per share. | 27 Oct 2025 | 3,184 | 93,971 (0%) | 0% | 33.4 | 106,473 | Class A Common Stock |
| Pricesmart Inc | Paul W. Kovaleski | EVP-Chief Merch. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 123.15 per share. | 27 Oct 2025 | 3,176 | 44,414 (0%) | 0% | 123.1 | 391,124 | Common Stock, $0.0001 par value per share |
| Robinhood Markets Inc (Class A) | Jeffrey Pinner | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 146.73 per share. | 27 Oct 2025 | 3,110 | 8,261 | - | 146.7 | 456,341 | Class A Common Stock |
| Atlassian Corp (Class A) | Scott Farquhar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 165.32 per share. | 27 Oct 2025 | 3,007 | 344,925 (0%) | 0% | 165.3 | 497,110 | Class A Common Stock |
| Atlassian Corp (Class A) | Michael Cannon-Brookes | Director, CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 165.32 per share. | 27 Oct 2025 | 3,006 | 348,934 (0%) | 0% | 165.3 | 496,944 | Class A Common Stock |
| Janover Inc | Parker White | COO & Chief Investment Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 6.94 per share. | 27 Oct 2025 | 3,003 | 252,115 | - | 6.9 | 20,841 | Common Stock |
| Ameriserv Fin Inc | Michael D. Lynch | EVP & CFO | 27 Oct 2025 | 3,000 | 11,119 | - | - | Stock Option (Right to Buy) | ||
| Ameriserv Fin Inc | Michael D. Lynch | EVP & CFO | 27 Oct 2025 | 3,000 | 20,892 (0%) | 0% | 3.0 | 8,880 | Common Stock | |
| Lam Research | Ava A. Harter | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 157.48 per share. | 27 Oct 2025 | 3,000 | 56,786 (0%) | 0% | 157.5 | 472,440 | Common Stock |
| Dolphin Entertainment Inc | William O’Dowd | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.64 per share. | 27 Oct 2025 | 3,000 | 390,788 (2%) | 0% | 1.6 | 4,920 | Common Stock |
| Origin Bancorp Inc | Jim Crotwell | Chief Risk Officer | Purchase of securities on an exchange or from another person at price $ 34.32 per share. | 27 Oct 2025 | 3,000 | 24,475 (0%) | 0% | 34.3 | 102,960 | Common Stock |
| PBF Energy Inc (Class A) | T. Paul Davis | Senior Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.44 per share. | 27 Oct 2025 | 2,998 | 162,038 (0%) | 0% | 33.4 | 100,253 | Class A Common Stock |
| PBF Energy Inc (Class A) | Thomas L. O'Connor | Senior Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.44 per share. | 27 Oct 2025 | 2,997 | 174,987 (0%) | 0% | 33.4 | 100,220 | Class A Common Stock |
| Synchrony Financial | Darrell Owens | See remarks | Sale of securities on an exchange or to another person at price $ 74.02 per share. | 27 Oct 2025 | 2,989 | 16,096 (0%) | 0% | 74.0 | 221,246 | Common Stock |
| Janover Inc | Daniel Kang | Chief Strategy Officer | Other type of transaction at price $ 0.00 per share. | 27 Oct 2025 | 2,981 | 2,981 | - | 0 | Common Stock | |
| Janover Inc | Daniel Kang | Chief Strategy Officer | Other type of transaction at price $ 0.00 per share. | 27 Oct 2025 | 2,981 | 46,852 | - | 0 | Common Stock | |
| PBF Energy Inc (Class A) | Trecia M. Canty | SVP and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.44 per share. | 27 Oct 2025 | 2,941 | 170,391 (0%) | 0% | 33.4 | 98,347 | Class A Common Stock |
| Boston Scientific | Ellen M. Zane | Director | Sale of securities on an exchange or to another person at price $ 102.24 per share. | 27 Oct 2025 | 2,901 | 24,134 (0%) | 0% | 102.2 | 296,599 | Common Stock |
| Trupanion Inc | Margaret Tooth | Director, CEO | Sale of securities on an exchange or to another person at price $ 43.74 per share. | 27 Oct 2025 | 2,884 | 141,345 (0%) | 0% | 43.7 | 126,153 | Common Stock |
| Equifax | Mark W. Begor | Director, CEO | Sale of securities on an exchange or to another person at price $ 233.12 per share. | 27 Oct 2025 | 2,801 | 40,517 (0%) | 0% | 233.1 | 652,979 | Common Stock |
| Hims & Hers Health Inc (Class A) | Soleil Boughton | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 50.10 per share. | 27 Oct 2025 | 2,637 | 158,493 | - | 50.1 | 132,114 | Class A Common Stock |
| Norfolk Southern | Richard H. Anderson | Director | Purchase of securities on an exchange or from another person at price $ 281.86 per share. | 27 Oct 2025 | 2,600 | 7,000 (0%) | 0% | 281.9 | 732,823 | Common Stock |
| FingerMotion Inc | Yew Poh Leong | Director | Purchase of securities on an exchange or from another person at price $ 1.55 per share. | 27 Oct 2025 | 2,500 | 192,500 | - | 1.6 | 3,875 | Common Stock |
| FingerMotion Inc | Yew Poh Leong | Director | Purchase of securities on an exchange or from another person at price $ 1.56 per share. | 27 Oct 2025 | 2,500 | 190,000 | - | 1.6 | 3,900 | Common Stock |
| Zions Bancorp N.A | Jennifer Anne Smith | Executive Vice President | 27 Oct 2025 | 2,457 | 27,132 (0%) | 0% | 53.1 | 130,519 | Common Stock | |
| WD-40 Co. | Steven A. Brass | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 27 Oct 2025 | 2,380 | 35,371 (0%) | 0% | - | Common Stock | |
| Synchrony Financial | Darrell Owens | See remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.26 per share. | 27 Oct 2025 | 2,377 | 19,085 (0%) | 0% | 72.3 | 171,762 | Common Stock |
| Natera Inc | Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 192.32 per share. | 27 Oct 2025 | 2,335 | 153,520 (0%) | 0% | 192.3 | 449,077 | Common Stock |
| Salesforce | Marc Benioff | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 2,250 | 9,122 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Salesforce | Marc Benioff | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 161.50 per share. | 27 Oct 2025 | 2,250 | 11,913,821 (1%) | 0% | 161.5 | 363,375 | Common Stock |
| Kratos Defense & Security Soln Inc | Steven Fendley | President, US Division | Sale of securities on an exchange or to another person at price $ 89.94 per share. | 27 Oct 2025 | 2,220 | 335,850 (0%) | 0% | 89.9 | 199,670 | Common Stock |
| Capital One | Richard D. Fairbank | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 227.42 per share. | 27 Oct 2025 | 2,122 | 4,101,228 (0%) | 0% | 227.4 | 482,585 | Common Stock |
| PBF Energy Inc (Class A) | Wendy Ho Tai | Senior Vice President, HR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.44 per share. | 27 Oct 2025 | 2,111 | 106,620 (0%) | 0% | 33.4 | 70,592 | Class A Common Stock |
| Neogen Corp | Amy M. Rocklin | Chief Legal Officer | 27 Oct 2025 | 2,085 | 57,240 (0%) | 0% | 6.2 | 12,906 | Common Stock | |
| Hexcel Corp | Lyndon John Smith | see remarks | 27 Oct 2025 | 2,077 | 8,426 (0%) | 0% | 73.0 | 151,663 | Common Stock | |
| Hexcel Corp | Lyndon John Smith | see remarks | 27 Oct 2025 | 2,077 | 10,503 (0%) | 0% | 41.7 | 86,632 | Common Stock | |
| Hexcel Corp | Lyndon John Smith | see remarks | 27 Oct 2025 | 2,077 | 0 | - | - | Non-Qualified Stock Options | ||
| Neogen Corp | Jeffrey D. Capello | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.19 per share. | 27 Oct 2025 | 2,025 | 30,725 (0%) | 0% | 6.2 | 12,535 | Common Stock |
| Neogen Corp | Jeffrey D. Capello | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 2,025 | 4,050 | - | - | Restricted Stock Units | |
| Neogen Corp | James C. Borel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.19 per share. | 27 Oct 2025 | 2,025 | 94,570 (0%) | 0% | 6.2 | 12,535 | Common Stock |
| Neogen Corp | James C. Borel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 2,025 | 4,050 | - | - | Restricted Stock Units | |
| Capital One | Richard D. Fairbank | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 227.42 per share. | 27 Oct 2025 | 2,023 | 4,051,228 (0%) | 0% | 227.4 | 460,071 | Common Stock |
| Mid Penn Bancorp Inc | John E. Noone | Director | Purchase of securities on an exchange or from another person at price $ 29.51 per share. | 27 Oct 2025 | 2,000 | 45,400 (0%) | 0% | 29.5 | 59,025 | Mid Penn Bancorp, Inc. Common Stock |
| Medpace Holdings Inc | Susan E Burwig | Exec. VP, Operations | Sale of securities on an exchange or to another person at price $ 605.01 per share. | 27 Oct 2025 | 2,000 | 65,500 (0%) | 0% | 605.0 | 1,210,020 | Common Stock |
| Plexus Corp | Patrick J. Jermain | Exec. VP & CFO | 27 Oct 2025 | 1,998 | 18,961 (0%) | 0% | 142.8 | 285,314 | Common Stock, $.01 par value | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 413.58 per share. | 27 Oct 2025 | 1,991 | 2,139 (0%) | 0% | 413.6 | 823,437 | Common Stock |
| Robinhood Markets Inc (Class A) | Jeffrey Pinner | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 147.52 per share. | 27 Oct 2025 | 1,973 | 6,288 | - | 147.5 | 291,055 | Class A Common Stock |
| WD-40 Co. | Steven A. Brass | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 27 Oct 2025 | 1,972 | 33,399 (0%) | 0% | - | Common Stock | |
| MACOM Tech Soln Holdings Inc | Stephen G. Daly | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 146.39 per share. | 27 Oct 2025 | 1,939 | 21,506 (0%) | 0% | 146.4 | 283,850 | Common Stock |
| Norwood Fin Corp | James Shook | Director | Purchase of securities on an exchange or from another person at price $ 26.63 per share. | 27 Oct 2025 | 1,937 | 4,730 (0%) | 0% | 26.6 | 51,582 | Common Stock |
| Micron Tech | Sanjay Mehrotra | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 221.32 per share. | 27 Oct 2025 | 1,885 | 450,175 (0%) | 0% | 221.3 | 417,188 | Common Stock |
| Zions Bancorp N.A | Jennifer Anne Smith | Executive Vice President | 27 Oct 2025 | 1,878 | 25,254 (0%) | 0% | 0 | Common Stock | ||
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 414.42 per share. | 27 Oct 2025 | 1,814 | 1,316 (0%) | 0% | 414.4 | 751,756 | Common Stock |
| Mercurity Fintech Holding Inc | Wilfred ZhongKei Daye | Director, CSO | Sale of securities on an exchange or to another person at price $ 11.48 per share. | 27 Oct 2025 | 1,800 | 58,399 | - | 11.5 | 20,664 | Common Stock |
| Neogen Corp | James P. Tobin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.19 per share. | 27 Oct 2025 | 1,777 | 43,347 (0%) | 0% | 6.2 | 11,000 | Common Stock |
| Neogen Corp | James P. Tobin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 1,777 | 1,777 | - | - | Restricted Stock Units | |
| Neogen Corp | Raphael A. Rodriguez | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.19 per share. | 27 Oct 2025 | 1,777 | 20,821 (0%) | 0% | 6.2 | 11,000 | Common Stock |
| Neogen Corp | Raphael A. Rodriguez | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 1,777 | 1,777 | - | - | Restricted Stock Units | |
| Neogen Corp | Catherine E. Woteki | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 1,777 | 1,777 | - | - | Restricted Stock Units | |
| Neogen Corp | Catherine E. Woteki | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.19 per share. | 27 Oct 2025 | 1,777 | 19,117 (0%) | 0% | 6.2 | 11,000 | Common Stock |
| Neogen Corp | Jeffrey D. Capello | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 1,777 | 1,777 | - | - | Restricted Stock Units | |
| Neogen Corp | Jeffrey D. Capello | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.19 per share. | 27 Oct 2025 | 1,777 | 32,502 (0%) | 0% | 6.2 | 11,000 | Common Stock |
| Neogen Corp | James C. Borel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 1,777 | 1,777 | - | - | Restricted Stock Units | |
| Neogen Corp | James C. Borel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.19 per share. | 27 Oct 2025 | 1,777 | 96,347 (0%) | 0% | 6.2 | 11,000 | Common Stock |
| Neogen Corp | Ronald D. Green | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 1,777 | 1,777 | - | - | Restricted Stock Units | |
| Neogen Corp | Ronald D. Green | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.19 per share. | 27 Oct 2025 | 1,777 | 18,654 (0%) | 0% | 6.2 | 11,000 | Common Stock |
| Neogen Corp | Aashima Gupta | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 1,777 | 1,777 | - | - | Restricted Stock Units | |
| Neogen Corp | Aashima Gupta | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.19 per share. | 27 Oct 2025 | 1,777 | 27,790 (0%) | 0% | 6.2 | 11,000 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 27 Oct 2025 | 1,750 | 7,875 (0%) | 0% | 146.0 | 255,553 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 1,750 | 0 | - | - | Stock Options | |
| Credo Tech Grp Holding Ltd | Chi Fung Cheng | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 159.64 per share. | 27 Oct 2025 | 1,719 | 6,672,347 | - | 159.6 | 274,418 | Ordinary Shares |
| Credo Tech Grp Holding Ltd | Chi Fung Cheng | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 160.46 per share. | 27 Oct 2025 | 1,686 | 6,670,661 | - | 160.5 | 270,541 | Ordinary Shares |
| United Community Banks Inc | Richard Bradshaw | EVP, Chief Banking Officer | Sale of securities on an exchange or to another person at price $ 30.23 per share. | 27 Oct 2025 | 1,654 | 75,226 (0%) | 0% | 30.2 | 50,000 | Common Stock |
| BridgeBio Pharma Inc | Frank P. McCormick | Director | Sale of securities on an exchange or to another person at price $ 65.00 per share. | 27 Oct 2025 | 1,641 | 878,338 (0%) | 0% | 65 | 106,665 | Common Stock |
| PBF Energy Inc (Class A) | James E. Fedena | Senior Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.44 per share. | 27 Oct 2025 | 1,581 | 133,850 (0%) | 0% | 33.4 | 52,869 | Class A Common Stock |
| Norwood Fin Corp | James Shook | Director | Purchase of securities on an exchange or from another person at price $ 26.82 per share. | 27 Oct 2025 | 1,563 | 2,593 (0%) | 0% | 26.8 | 41,920 | Common Stock |
| Waterstone Fin Inc | Michael L. Hansen | Director | 27 Oct 2025 | 1,541 | 0 (0%) | 0% | 15.2 | 23,362 | Common Stock | |
| Kratos Defense & Security Soln Inc | Steven Fendley | President, US Division | Sale of securities on an exchange or to another person at price $ 93.22 per share. | 27 Oct 2025 | 1,516 | 333,156 (0%) | 0% | 93.2 | 141,325 | Common Stock |
| Yelp Inc | Carmen Amara | Chief People Officer | Sale of securities on an exchange or to another person at price $ 33.04 per share. | 27 Oct 2025 | 1,500 | 82,566 (0%) | 0% | 33.0 | 49,560 | Common Stock |
| IPG Photonics Corp | Angelo P. Lopresti | SVP, Secretary & Gen Counsel, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 87.13 per share. | 27 Oct 2025 | 1,500 | 61,385 (0%) | 0% | 87.1 | 130,695 | Common Stock |
| Dorian LPG Ltd | John C. Hadjipateras | Director, President and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 27 Oct 2025 | 1,500 | 1,856,838 (3%) | 0% | 0 | Common Shares, $0.01 par value per share | |
| State Street | Michael L. Richards | EVP and Senior Advisor | Sale of securities on an exchange or to another person at price $ 117.24 per share. | 27 Oct 2025 | 1,500 | 38,626 (0%) | 0% | 117.2 | 175,860 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 417.92 per share. | 27 Oct 2025 | 1,500 | 130 (0%) | 0% | 417.9 | 626,873 | Common Stock |
| Salesforce | Marc Benioff | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 255.79 per share. | 27 Oct 2025 | 1,475 | 11,912,346 (1%) | 0% | 255.8 | 377,288 | Common Stock |
| Concentrix Corp | Craig Gibson | EVP, Global Sales, Acct Mgmt | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.04 per share. | 27 Oct 2025 | 1,403 | 41,008 | - | 46.0 | 64,594 | Common Stock |
| Guidewire Software Inc | Michael Rosenbaum | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 255.40 per share. | 27 Oct 2025 | 1,400 | 256,558 (0%) | 0% | 255.4 | 357,560 | Common Stock |
| Kratos Defense & Security Soln Inc | Steven Fendley | President, US Division | Sale of securities on an exchange or to another person at price $ 89.12 per share. | 27 Oct 2025 | 1,351 | 338,070 (0%) | 0% | 89.1 | 120,407 | Common Stock |
| Credo Tech Grp Holding Ltd | Chi Fung Cheng | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 161.62 per share. | 27 Oct 2025 | 1,300 | 6,669,361 | - | 161.6 | 210,111 | Ordinary Shares |
| Natera Inc | Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 191.46 per share. | 27 Oct 2025 | 1,237 | 67,171 (0%) | 0% | 191.5 | 236,838 | Common Stock |
| Natera Inc | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 191.46 per share. | 27 Oct 2025 | 1,198 | 115,061 (0%) | 0% | 191.5 | 229,371 | Common Stock |
| Flex Ltd | Kwang Hooi Tan | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 65.51 per share. | 27 Oct 2025 | 1,188 | 251,136 (0%) | 0% | 65.5 | 77,831 | Ordinary Shares |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 420.29 per share. | 27 Oct 2025 | 1,186 | 130 (0%) | 0% | 420.3 | 498,462 | Common Stock |
| Liquidia Corp | Dana Boyle | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 22.93 per share. | 27 Oct 2025 | 1,073 | 184,338 (0%) | 0% | 22.9 | 24,604 | Common Stock |
| Natera Inc | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 191.46 per share. | 27 Oct 2025 | 1,058 | 201,699 (0%) | 0% | 191.5 | 202,567 | Common Stock |
| Credo Tech Grp Holding Ltd | Chi Fung Cheng | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 158.47 per share. | 27 Oct 2025 | 1,040 | 6,674,066 | - | 158.5 | 164,812 | Ordinary Shares |
| Commvault Systems Inc | William Geoffrey Haydon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 1,027 | 1,027 (0%) | 0% | 0 | Common Stock | |
| Natera Inc | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 192.32 per share. | 27 Oct 2025 | 1,008 | 116,259 (0%) | 0% | 192.3 | 193,863 | Common Stock |
| WD-40 Co. | Daniel T. Carter | Director | Purchase of securities on an exchange or from another person at price $ 199.37 per share. | 27 Oct 2025 | 1,000 | 7,205 (0%) | 0% | 199.4 | 199,370 | Common Stock |
| Metropolitan Bank Holding Corp | Daniel F. Dougherty | EVP & Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 71.66 per share. | 27 Oct 2025 | 1,000 | 27,341 (0%) | 0% | 71.7 | 71,660 | Common Stock |
| Origin Bancorp Inc | James S. D'Agostino | Director | Purchase of securities on an exchange or from another person at price $ 33.93 per share. | 27 Oct 2025 | 1,000 | 47,917 (0%) | 0% | 33.9 | 33,930 | Common Stock |
| Swiss Helvetia Fund Inc | Moritz A. Sell | Director | Purchase of securities on an exchange or from another person at price $ 6.06 per share. | 27 Oct 2025 | 1,000 | 4,400 (0%) | 0% | 6.1 | 6,055 | Common Stock |
| Cathay General Bancorp | Thomas M. Lo | EVP, Chief Admin Officer | Sale of securities on an exchange or to another person at price $ 46.83 per share. | 27 Oct 2025 | 1,000 | 3,000 (0%) | 0% | 46.8 | 46,828 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 411.96 per share. | 27 Oct 2025 | 1,000 | 3,130 (0%) | 0% | 412.0 | 411,955 | Common Stock |
| Lindsay Corp | James Scott Marion | President - Infrastructure | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 983 | 8,375 (0%) | 0% | 0 | Common Stock | |
| Lindsay Corp | Gustavo E. Oberto | President - Irrigation | 27 Oct 2025 | 983 | 6,907 (0%) | 0% | 0 | Common Stock | ||
| Natera Inc | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 192.32 per share. | 27 Oct 2025 | 935 | 202,757 (0%) | 0% | 192.3 | 179,823 | Common Stock |
| Natera Inc | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 191.46 per share. | 27 Oct 2025 | 928 | 150,699 (0%) | 0% | 191.5 | 177,677 | Common Stock |
| BlackLine Inc | Thomas Unterman | Director | 27 Oct 2025 | 910 | 41,835 (0%) | 0% | 55 | 50,050 | Common Stock | |
| Goosehead Insurance Inc (Class A) | Mark E. Jones | CFO & COO, Ten Percent Owner, Member of 10% owner group | Purchase of securities on an exchange or from another person at price $ 74.44 per share. | 27 Oct 2025 | 866 | 4,364 (0%) | 0% | 74.4 | 64,465 | Class A Common Stock |
| Expedia Group | Henrique Dubugras | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 861 | 5,062 (0%) | 0% | 0 | Common Stock | |
| Expedia Group | Henrique Dubugras | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 861 | 0 | - | - | Restricted Stock Units | |
| Aehr Test Systems | Gayn Erickson | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.14 per share. | 27 Oct 2025 | 819 | 261,095 (1%) | 0% | 25.1 | 20,590 | Common Stock |
| Origin Bancorp Inc | Drake Mills | Director, Chairman, President and CEO | Purchase of securities on an exchange or from another person at price $ 34.08 per share. | 27 Oct 2025 | 800 | 148,634 (0%) | 0% | 34.1 | 27,264 | Common Stock |
| MACOM Tech Soln Holdings Inc | John F. Kober | Senior VP and CFO | Sale of securities on an exchange or to another person at price $ 145.10 per share. | 27 Oct 2025 | 797 | 44,280 (0%) | 0% | 145.1 | 115,645 | Common Stock |
| McCormick & Company | Jacques Tapiero | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 792 | 2,190 | - | - | Phantom Stock | |
| McCormick & Company | Jacques Tapiero | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 67.31 per share. | 27 Oct 2025 | 792 | 31,590 (0%) | 0% | 67.3 | 53,310 | Common Stock - Voting |
| Natera Inc | Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 192.32 per share. | 27 Oct 2025 | 781 | 68,408 (0%) | 0% | 192.3 | 150,205 | Common Stock |
| Natera Inc | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 192.32 per share. | 27 Oct 2025 | 781 | 151,627 (0%) | 0% | 192.3 | 150,205 | Common Stock |
| Ladder Cap Corp (Class A) | Alan H. Fishman | Director | 27 Oct 2025 | 775 | 775 (0%) | 0% | 0 | Class A Common Stock | ||
| Kratos Defense & Security Soln Inc | Steven Fendley | President, US Division | Sale of securities on an exchange or to another person at price $ 94.18 per share. | 27 Oct 2025 | 735 | 332,421 (0%) | 0% | 94.2 | 69,224 | Common Stock |
| Origin Bancorp Inc | Derek McGee | Chief Legal Counsel | Purchase of securities on an exchange or from another person at price $ 34.25 per share. | 27 Oct 2025 | 732 | 1,467 (0%) | 0% | 34.3 | 25,071 | Common Stock |
| National Bank Holdings Corp (Class A) | Alka Gupta | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.20 per share. | 27 Oct 2025 | 729 | 3,412 (0%) | 0% | 37.2 | 27,119 | Common Stock |
| Iradimed Corp | Roger Susi | Director, CEO, PRESIDENT, CHAIRMAN, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 78.33 per share. | 27 Oct 2025 | 700 | 2,327,558 (20%) | 0% | 78.3 | 54,831 | Common Stock |
| Origin Bancorp Inc | Stephen H. Brolly | Chief Accounting Officer | Purchase of securities on an exchange or from another person at price $ 34.94 per share. | 27 Oct 2025 | 700 | 22,324 (0%) | 0% | 34.9 | 24,458 | Common Stock |
| Transdigm Group | Kevin M. Stein | Director | 27 Oct 2025 | 700 | 72,800 | - | - | Stock Option | ||
| Transdigm Group | Kevin M. Stein | Director | 27 Oct 2025 | 700 | 8,158 (0%) | 0% | 1360 | 952,000 | Common Stock | |
| Transdigm Group | Kevin M. Stein | Director | 27 Oct 2025 | 700 | 8,858 (0%) | 0% | 105.9 | 74,116 | Common Stock | |
| MACOM Tech Soln Holdings Inc | John F. Kober | Senior VP and CFO | Sale of securities on an exchange or to another person at price $ 146.01 per share. | 27 Oct 2025 | 700 | 43,580 (0%) | 0% | 146.0 | 102,207 | Common Stock |
| National Bank Holdings Corp (Class A) | Micho F. Spring | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.20 per share. | 27 Oct 2025 | 696 | 41,877 (0%) | 0% | 37.2 | 25,891 | Common Stock |
| Liquidia Corp | Jason Adair | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 22.93 per share. | 27 Oct 2025 | 692 | 174,998 (0%) | 0% | 22.9 | 15,868 | Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.